NASDAQ:INOV

Inovalon Stock Forecast, Price & News

$32.80
+0.25 (+0.77 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$32.65
$32.97
50-Day Range
$29.09
$32.80
52-Week Range
$17.50
$32.97
Volume252,903 shs
Average Volume452,712 shs
Market Capitalization$5.11 billion
P/E Ratio149.09
Dividend YieldN/A
Beta0.59
30 days | 90 days | 365 days | Advanced Chart
Receive INOV News and Ratings via Email

Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter.


Inovalon logo

About Inovalon

Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, an integrated, real-time cloud native platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately one million physicians; 574,000 clinical facilities; and approximately 332 million individuals and 61 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.24 out of 5 stars

Computer And Technology Sector

573rd out of 1,582 stocks

Data Processing & Preparation Industry

50th out of 108 stocks

Analyst Opinion: 1.2Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Inovalon (NASDAQ:INOV) Frequently Asked Questions

Is Inovalon a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Inovalon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INOV, but not buy additional shares or sell existing shares.
View analyst ratings for Inovalon
or view top-rated stocks.

What stocks does MarketBeat like better than Inovalon?

Wall Street analysts have given Inovalon a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Inovalon wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Inovalon's next earnings date?

Inovalon is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Inovalon
.

How were Inovalon's earnings last quarter?

Inovalon Holdings, Inc. (NASDAQ:INOV) announced its quarterly earnings data on Wednesday, April, 28th. The technology company reported $0.17 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.15 by $0.02. The technology company had revenue of $177.18 million for the quarter, compared to analysts' expectations of $174.09 million. Inovalon had a trailing twelve-month return on equity of 11.31% and a net margin of 4.71%. The company's revenue for the quarter was up 14.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.11 EPS.
View Inovalon's earnings history
.

How has Inovalon's stock been impacted by COVID-19?

Inovalon's stock was trading at $17.36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, INOV stock has increased by 88.9% and is now trading at $32.80.
View which stocks have been most impacted by COVID-19
.

What guidance has Inovalon issued on next quarter's earnings?

Inovalon updated its FY 2021 earnings guidance on Wednesday, May, 5th. The company provided earnings per share (EPS) guidance of 0.730-0.750 for the period, compared to the Thomson Reuters consensus estimate of $0.750. The company issued revenue guidance of $745 million-$772 million, compared to the consensus revenue estimate of $756.10 million.

What price target have analysts set for INOV?

7 equities research analysts have issued 12 month price objectives for Inovalon's shares. Their forecasts range from $22.00 to $40.00. On average, they anticipate Inovalon's share price to reach $30.00 in the next year. This suggests that the stock has a possible downside of 8.5%.
View analysts' price targets for Inovalon
or view top-rated stocks among Wall Street analysts.

Who are Inovalon's key executives?

Inovalon's management team includes the following people:
  • Dr. Keith R. Dunleavy, Founder, Chairman & CEO (Age 52, Pay $211.83k)
  • Mr. Jonathan R. Boldt CPA, Chief Financial Officer (Age 36, Pay $561.95k)
  • Mr. Peter De Bock, Chief Admin. Officer (Age 58, Pay $648.53k)
  • Mr. Jason B. Capitel, Chief Commercial Officer (Age 49, Pay $779.15k)
  • Mr. Geoff Charron, Chief Technology Officer
  • Hulus Alpay, VP of Investor Relations
  • Ms. Beverly Allen, Gen. Counsel, Chief Compliance & Privacy Officer
  • Kim E. Collins, Sr. VP of Corp. Marketing & Communications
  • Ms. Ingrid E. Olsen, Chief People Officer
  • Dr. Paige C. Kilian M.D., Chief Medical Officer

What is Keith R. Dunleavy's approval rating as Inovalon's CEO?

410 employees have rated Inovalon CEO Keith R. Dunleavy on Glassdoor.com. Keith R. Dunleavy has an approval rating of 57% among Inovalon's employees. This puts Keith R. Dunleavy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Inovalon's key competitors?

What other stocks do shareholders of Inovalon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Digital Turbine (APPS), PayPal (PYPL), Square (SQ), Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH).

When did Inovalon IPO?

(INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

Who are Inovalon's major shareholders?

Inovalon's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.38%), Black Creek Investment Management Inc. (2.33%), Neuberger Berman Group LLC (1.53%), Eaton Vance Management (1.51%), Oak Ridge Investments LLC (1.05%) and Bernzott Capital Advisors (1.03%). Company insiders that own Inovalon stock include Bock Peter De, Jason Capitel, Jonathan R Boldt, Keith R Dunleavy, Mark Pulido, Robert A Wychulis and William J Teuber Jr.
View institutional ownership trends for Inovalon
.

Which major investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Goldman Sachs Group Inc., Black Creek Investment Management Inc., Panagora Asset Management Inc., Millennium Management LLC, Federated Hermes Inc., Prosight Management LP, and Neuberger Berman Group LLC. Company insiders that have sold Inovalon company stock in the last year include Jason Capitel, Jonathan R Boldt, and Mark Pulido.
View insider buying and selling activity for Inovalon
or view top insider-selling stocks.

Which major investors are buying Inovalon stock?

INOV stock was bought by a variety of institutional investors in the last quarter, including Eaton Vance Management, Oak Ridge Investments LLC, Royal Bank of Canada, BlackRock Inc., Spence Asset Management, Oak Ridge Investments LLC, Mirae Asset Global Investments Co. Ltd., and Bank Julius Baer & Co. Ltd Zurich. Company insiders that have bought Inovalon stock in the last two years include Bock Peter De, Keith R Dunleavy, and William J Teuber Jr.
View insider buying and selling activity for Inovalon
or or view top insider-buying stocks.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $32.80.

How much money does Inovalon make?

Inovalon has a market capitalization of $5.11 billion and generates $667.52 million in revenue each year. The technology company earns $22.58 million in net income (profit) each year or $0.48 on an earnings per share basis.

How many employees does Inovalon have?

Inovalon employs 2,662 workers across the globe.

What is Inovalon's official website?

The official website for Inovalon is www.inovalon.com.

Where are Inovalon's headquarters?

Inovalon is headquartered at 4321 COLLINGTON ROAD, BOWIE MD, 20716.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]


This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.